These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15081150

  • 21. Liposomal amphotericin B dry powder inhaler: effect of fines on in vitro performance.
    Shah SP, Misra A.
    Pharmazie; 2004 Oct; 59(10):812-3. PubMed ID: 15544064
    [Abstract] [Full Text] [Related]

  • 22. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y.
    Int J Pharm; 2010 Jan 29; 385(1-2):66-72. PubMed ID: 19853028
    [Abstract] [Full Text] [Related]

  • 23. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H, Larson I, Stewart PJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):229-38. PubMed ID: 17303354
    [Abstract] [Full Text] [Related]

  • 24. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW, Lim LT, Heng PW.
    J Pharm Sci; 2003 May 07; 92(5):975-84. PubMed ID: 12712417
    [Abstract] [Full Text] [Related]

  • 25. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®.
    Hoe S, Young PM, Traini D.
    Drug Dev Ind Pharm; 2011 Nov 07; 37(11):1365-75. PubMed ID: 21554161
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

  • 27. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
    Jones MD, Harris H, Hooton JC, Shur J, King GS, Mathoulin CA, Nichol K, Smith TL, Dawson ML, Ferrie AR, Price R.
    Eur J Pharm Biopharm; 2008 Jun 20; 69(2):496-507. PubMed ID: 18191553
    [Abstract] [Full Text] [Related]

  • 28. Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation.
    Giry K, Péan JM, Giraud L, Marsas S, Rolland H, Wüthrich P.
    Int J Pharm; 2006 Sep 14; 321(1-2):162-6. PubMed ID: 16797150
    [Abstract] [Full Text] [Related]

  • 29. Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier.
    Hassan MS, Lau R.
    Int J Pharm; 2010 Feb 15; 386(1-2):6-14. PubMed ID: 19922775
    [Abstract] [Full Text] [Related]

  • 30. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):72-80. PubMed ID: 16442248
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Influence of carrier surface fines on dry powder inhalation formulations.
    Boshhiha AM, Urbanetz NA.
    Drug Dev Ind Pharm; 2009 Aug 09; 35(8):904-16. PubMed ID: 19466888
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.
    Young PM, Chan HK, Chiou H, Edge S, Tee TH, Traini D.
    J Pharm Sci; 2007 May 09; 96(5):1331-41. PubMed ID: 17455362
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".
    Young PM, Cocconi D, Colombo P, Bettini R, Price R, Steele DF, Tobyn MJ.
    J Pharm Pharmacol; 2002 Oct 09; 54(10):1339-44. PubMed ID: 12396294
    [Abstract] [Full Text] [Related]

  • 36. Formulation development of inhalation powders for FK888 with carrier lactose using Spinhaler and its absorption in healthy volunteers.
    Nakate T, Yoshida H, Ohike A, Tokunaga Y, Ibuki R, Kawashima Y.
    J Control Release; 2004 May 31; 97(1):19-29. PubMed ID: 15147801
    [Abstract] [Full Text] [Related]

  • 37. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A, Boireau H, Horta MJ, Vanbever R.
    Eur J Pharm Biopharm; 2008 Nov 31; 70(3):839-44. PubMed ID: 18620052
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM, Wood O, Ooi J, Traini D.
    Int J Pharm; 2011 Sep 15; 416(1):129-35. PubMed ID: 21708238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.